GlaxoSmithKline

Do more, feel better, live longer

History and Evolution 1924, Glaxo came to India as H J Foster & Co. | Parent Company GSK plc, UK, one of the world's leading research-
based pharmaceutical & healthcare companies | Manufactures prescription medicines/ vaccines | Has operations
across pharmaceuticals, vaccines and consumer health domains | GSK Global Headquarters: London, UK | GSK
India headquarters: Mumbai, Maharashtra
Read more Detailed History here
Goal Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies. Link
Strategy Our strategy is to bring differentiated, high-quality and needed healthcare products to as many people as
possible, with our three global businesses, scientific and technical know-how and talented people. Link
Values & Expectations Our values and expectations are at the heart of everything we do and form an important part of our culture.
Our values are Patient focus, Transparency, Respect, Integrity.
Our expectations are Courage, Accountability, Development, Teamwork. Link
Financials FY 2017: Revenues : INR 2896 crores, Earnings Per Share: INR 41.6, Net Profit: INR 352 crores

Key People Emma Walmsley [CEO]

Dr Hal Barron [Chief Scientific Officer and President, R&D]
Roger Connor [President, Global Manufacturing and Supply]
GSK India:- D. S. Parekh [Chairman & Non-Executive Director]
A. Vaidheesh [Managing Director India]

PLACEMENT PREPARATION COMMITTEE, IIM INDORE

Business Description
3 Business
Areas

Pharmaceutical Vaccines

• Manufacturing unit is located at Nashik

• Clinical development centre is in Bangalore
• Prescription medicines range across therapeutic areas such as, analgesic, anti-infective, anti-inflammatory, anti-
parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology etc.
• Range of vaccines for the prevention of hepatitis A, hepatitis B, influenzae, diphtheria, tetanus, pertussis, rotavirus
etc.
• Company Presence : Global
• No. Of Employees: Over 4,500

PLACEMENT PREPARATION COMMITTEE, IIM INDORE

Company Analysis
• At GSK, they have an evolving business model for a sustainable future
• Focused around five strategic priorities
• Grow a diversified global business
• Deliver more products of value
• Simplify the operating model
• Create a culture of individual empowerment
• Build trust
• The company’s research and development (R&D) has collaborations with more than 3,000 external
organizations worldwide. It has three global R&D hubs - at Rockville, USA; Rixensart, Belgium and Siena, Italy
• Started construction of its largest Indian tablet manufacturing pharmaceutical factory in Vemgal, Karnataka
• Builds capacities through dual sourcing for key products
• The company's future plans include introduction of new strengths for Eltroxin tablets; support Greenfield
project team to deploy latest technology; continue technical support for India strategy; enhance process
robustness to minimize the waste; and identify and work on opportunities related to pack redesign,
configuration, barcoding and serialization
• The company reported higher cost structure in FY2017 which affected its operating performance

PLACEMENT PREPARATION COMMITTEE, IIM INDORE

Product Suite
Medicines Vaccines

• Prescription drugs • Around 40% of the world’s children are

• Prescription Drugs List here immunised against at least one serious
• Non prescription drugs disease with a GSK vaccine.
• List of non prescription drugs here • View complete list of vaccines here

Famous brands include: GSK’s Consumer Healthcare division is being

sold to HUL.
• Calpol
• Augmentin (IV) and Augmentin (ORAL) Major brands of this division include:
• Ceftum • Horlicks
• Eno
• Neosporin EYE Drops
• Iodex
• Phexin • Sensodyne
• Zovirax • Crocin
• Betnesol etc. • Boost

PLACEMENT PREPARATION COMMITTEE, IIM INDORE

Competitors
• Major competitors of the company in India include:
• Sun Pharmaceutical Industries Limited
• Lupin Limited
• Cipla Ltd.
• Aarti Drugs Ltd.
• Ambalal Sarabhai Enterprises Limited
• Aurobindo Pharma Ltd
• Bliss GVS Pharma Limited
• Dr. Reddy's Laboratories Ltd.
• Morepen Laboratories Limited
• Ranbaxy Laboratories Limited
• Solvay Pharma India Ltd., and other

PLACEMENT PREPARATION COMMITTEE, IIM INDORE

In News
• Glaxo to split into two after mega merger deal with Pfizer Link (19 Dec 2018)
GlaxoSmithKline Plc paved the way for a split into two companies, agreeing to create a consumer-health joint venture with
Pfizer Inc. that the pharma giants plan to list on the stock market.

• Merger with GSK will take food and refreshment business to over Rs 10,000 crore, says HUL Link
(17 Dec 2018)
In one of the biggest deals across the consumer goods space, Hindustan Unilever (HUL) has bought GSK's India
business for around $3.8 billion. The deal increases the consumer goods giant's footprint in one of the world's fastest-
growing economies.

• Steer Engineering moves Delhi HC against GSK Consumer over Unilever deal Link (9 Dec 2018)
Bengaluru-based Steer Engineering has moved the Delhi High Court seeking protection of the technology and know-how
that it provided to GSK Consumer Healthcare in India. The technology is used for the manufacture of food and malt-based
drinks such as Horlicks and Boost.

• GlaxoSmithKline to acquire Tesaro to strengthen pharmaceuticals business Link (8 Dec 2018)

GlaxoSmithKline is buying Tesaro, a company developing drugs for cancer treatment, for approximately $5.1 billion.
Though it will be 2020 before it increases GlaxoSmithKline’s bottom line, CEO Emma Walsmley cites increased
capabilities in oncological research and treatment. Having sold its oncology assets in 2015, the acquisition marks a fresh
start for CEO Walsmley.

PLACEMENT PREPARATION COMMITTEE, IIM INDORE